Clinical Trial Examines Synthetic Psilocybin as a Treatment for Severe Depression
Participants in a double-blind trial on depression found temporary relief with a synthetic formulation of psilocybin, COMP360.
November 4, 2022
Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows
COMPASS Pathways psilocybin study shows a significant improvement in treatment-resistant depression symptoms.
May 24, 2022